Asset Management One
JUNO

Asset Management One’s Juno Therapeutics, Inc. JUNO Stock Holding History

Asset Management One’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-53,881
Closed -$2.56M – 1110
2017
Q4 		$2.56M Hold
53,881
– – 0.01% 827
2017
Q3 		$2.4M Buy
+53,881
New +$1.84M 0.01% 821

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Asset Management One's JUNO Position: Q1 2018 in Review

Asset Management One sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 53,881 shares — an estimated $2.56M sold.

Asset Management One first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $2.56M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Asset Management One reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Asset Management One sold 53,881 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $2.56M.
  • Asset Management One first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Asset Management One's Juno Therapeutics, Inc. position peaked at $2.56M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Asset Management One's 13F filing for Q1 2018, filed 14 May 2018.